Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Poolbeg Pharma (POLB) Share Price

Price 6.50p on 29-10-2026 at 19:25:07
Change -0.15p -2.26%
Buy 6.70p
Sell 6.30p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 18,600.00 at 6.541p
Day's Volume: 308,684
Last Close: 6.50p
Open: 6.65p
ISIN: GB00BKPG7Z60
Day's Range 6.50p - 6.65p
52wk Range: 3.40p - 9.15p
Market Capitalisation: £49.62m
VWAP: 6.514466p
Shares in Issue: 763.44m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Poolbeg Pharma (POLB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 18,600 6.541p Ordinary
 16:13:48 - 29-Oct-26
Buy* 3,793 6.59p Ordinary
 15:22:26 - 29-Oct-26
Buy* 7,568 6.541p Ordinary
 15:20:34 - 29-Oct-26
Buy* 7,261 6.541p Ordinary
 15:16:12 - 29-Oct-26
Sell* 3,175 6.415p Ordinary
 14:32:59 - 29-Oct-26
Buy* 609 6.568p Ordinary
 14:31:41 - 29-Oct-26
Buy* 12 6.60p Ordinary
 12:57:31 - 29-Oct-26
Buy* 4 6.60p Ordinary
 12:34:42 - 29-Oct-26
Buy* 7,610 6.57p Ordinary
 11:44:47 - 29-Oct-26
Sell* 3,000 6.332p Ordinary
 10:48:51 - 29-Oct-26
See more Poolbeg Pharma trades

Poolbeg Pharma (POLB) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Oct 2026 (Thu) 6.65 6.65 6.50 6.50 308,684
28th Oct 2026 (Wed) 6.65 6.65 6.65 6.65 460,487
27th Oct 2026 (Tue) 6.75 6.75 6.65 6.65 789,262
26th Oct 2026 (Mon) 6.45 6.75 6.45 6.75 1,555,347
23rd Oct 2026 (Fri) 6.50 6.66 6.66 6.66 297,452
22nd Oct 2026 (Thu) 6.25 6.55 6.40 6.50 1,865,440
21st Oct 2026 (Wed) 6.25 6.25 6.15 6.25 2,248,691
20th Oct 2026 (Tue) 6.25 6.25 6.25 6.25 584,172
19th Oct 2026 (Mon) 6.30 6.40 6.25 6.25 247,084
16th Oct 2026 (Fri) 6.40 6.40 6.15 6.30 929,303
15th Oct 2026 (Thu) 6.35 6.60 6.60 6.60 643,303
14th Oct 2026 (Wed) 6.50 6.50 6.40 6.40 1,580,965
13th Oct 2026 (Tue) 6.90 6.90 6.35 6.50 2,972,310
12th Oct 2026 (Mon) 6.90 6.90 6.90 6.90 412,833
9th Oct 2026 (Fri) 6.90 6.90 6.90 6.90 583,157
8th Oct 2026 (Thu) 6.90 6.90 6.90 6.90 489,106
7th Oct 2026 (Wed) 7.15 6.90 6.90 6.90 3,245,620
6th Oct 2026 (Tue) 7.10 7.20 7.20 7.20 831,444
5th Oct 2026 (Mon) 7.10 7.00 6.90 7.00 594,915
2nd Oct 2026 (Fri) 7.35 7.18 7.18 7.18 1,127,008
1st Oct 2026 (Thu) 7.35 7.35 7.35 7.35 1,029,435
30th Sep 2026 (Wed) 7.40 7.40 7.35 7.40 554,884
See more Poolbeg Pharma price history

Poolbeg Pharma (POLB) Regulatory News

Date Source Headline
6th Oct 2026 7:00 am RNS POLB001 CRS Patent Granted in South Korea
29th Sep 2026 7:00 am RNS Interim Results for the six months to 30 June 2026
28th Sep 2026 7:00 am RNS-R POLB 001 TOPICAL trial recruitment update
24th Sep 2026 7:00 am RNS Interim data from POLB 001 TOPICAL clinical trial
14th Sep 2026 11:58 am RNS Notification of Major Holdings
3rd Sep 2026 7:00 am RNS-R Key Conference Participation in September 2026
23rd Jul 2026 11:05 am RNS Notification of major holdings
22nd Jul 2026 7:00 am RNS Notification of Major Holdings
21st Jul 2026 7:00 am RNS-R Notice of Allowance for POLB 001 patent in Israel
14th Jul 2026 7:00 am RNS Placing to raise £3.5 million
See more Poolbeg Pharma regulatory news

Poolbeg Pharma (POLB) Share News

EARNINGS: Poolbeg Pharma loss narrows; Zanaga Iron Ore loss widens

29th Sep 2026 20:03

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Bango "cautiously optimistic" as earnings grow

25th Sep 2026 11:03

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

TRADING UPDATES: Zenith private placement; CyanConnode revised offer

21st Jul 2026 19:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Poolbeg Pharma raises GBP3.5 million in share placing

15th Jul 2026 06:59

Poolbeg Pharma PLC - London-based biopharmaceutical firm focused on cancer immunotherapy - Raises GBP3.5 million from a placing of 58.3 million new shares at 6 pence each. The placing price is a discount of 16% from the stock's closing market price on Monday. The funds will be used to fund two drug trials through to completion, extending Poolbeg's cash runway into the second quarter of 2028. The share placing is run by broker Oak Securities. "This successful fundraise is a great market endorsement of Poolbeg, our strategy and pipeline," says Chief Executive Officer Jeremny Skillington. "Not only does it extend our expected cash runway into Q2 2028, but it strengthens the company's position in ongoing partnering discussions." Read More

WINNERS & LOSERS: Ironveld's plant in production; Headlam revenue down

14th Jul 2026 11:16

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

See more Poolbeg Pharma news
FTSE 100 Latest
Value10,722.07
Change27.57

Login to your account

Forgot Password?

Not Registered